Our clients rely on us to solve their most complex, business-critical IP, data and commercial challenges, wherever they arise.
On major transactions, you need lawyers that can resolve difficult IP, data and commercial issues quickly and globally. We’ve advised on many of the biggest and most IP-heavy deals worldwide – including in M&A, IPOs and re-structurings.
And if you need to assert or defend your rights in court, we can help. We have a leading patent litigation practice across the key jurisdictions of the UK, Germany and the Netherlands. We regularly co-ordinate cases across several countries. We’ve run some of the world’s most high-profile cases, particularly in tech and pharma.
Advising AB InBev on its £78.4bn acquisition of SABMiller, a deal that combined the world’s two largest beer makers, and on the separation and IP aspects of various related business divestments.
Advising Novartis on the sale of its animal health business to Eli Lilly and the contribution of its over-the-counter business into a joint venture with GlaxoSmithKline.
Advising BMS and its partner Ono Pharmaceutical on the European aspects of their global patent dispute with Merck across nine jurisdictions relating to BMS’s ground-breaking immunotherapy cancer drug.
Advising London Stock Exchange Group on IP and IT matters relating to its proposed merger with Deutsche Börse, including advising on separation aspects in connection with its remedy arrangements.